These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4249163)
21. [The use of hexafluorenium (mylaxen) in anesthesia]. Hudon R; Prud'homme G Union Med Can; 1967 Mar; 96(3):290-4. PubMed ID: 5615018 [No Abstract] [Full Text] [Related]
22. [Clinical and electrophysiologil studies on muscle relaxation with hexafluorenium and succinylcholine]. Dick W; Droh R; Sollberg G Anaesthesist; 1969 Oct; 18(10):326-30. PubMed ID: 5398056 [No Abstract] [Full Text] [Related]
23. [THE COMBINATION OF HEXAFLUORENIUM, SUCCINYLCHOLINE AND FLUOTHANE IN ANESTHESIA. PRELIMINARY NOTE]. RIZZI R; GIUSSANI A Acta Anaesthesiol; 1964; 15():53-62. PubMed ID: 14131757 [No Abstract] [Full Text] [Related]
24. Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments. Savarese JJ; Antonio RP; Ginsburg S Anesth Analg; 1975; 54(5):669-78. PubMed ID: 126651 [TBL] [Abstract][Full Text] [Related]
26. The effect of pretreatment with nondepolarizing muscle relaxants on the neuromuscular blocking action of succinylcholine. Cullen DJ Anesthesiology; 1971 Dec; 35(6):572-8. PubMed ID: 4256556 [No Abstract] [Full Text] [Related]
27. Relaxants for endotracheal intubation. A comparison of depolarizing and non-depolarizing neuromuscular blocking agents. Hey VM Anaesthesia; 1973 Jan; 28(1):32-6. PubMed ID: 4265662 [No Abstract] [Full Text] [Related]
28. [Electromyographic studies of the supposed interference of Trasylol in neuromuscular block induced with curariform drugs]. Manani G; Gritti G; Vecchini L; Manzin E; Merli GA Acta Anaesthesiol; 1968; 19():Suppl 9:1-21. PubMed ID: 4247861 [No Abstract] [Full Text] [Related]
29. Neuromuscular monitoring: does it make a difference? Martin R; Bourdua I; Thériault S; Tétrault JP; Pilote M Can J Anaesth; 1996 Jun; 43(6):585-8. PubMed ID: 8773865 [TBL] [Abstract][Full Text] [Related]
30. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase. Baraka A Br J Anaesth; 1975 Aug; 47(8):885-8. PubMed ID: 1201167 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacology of a new muscle relaxant--dioxonium]. Kimenis AA; Klusha VE; Ginters IaIa Farmakol Toksikol; 1972; 35(2):172-5. PubMed ID: 4259940 [No Abstract] [Full Text] [Related]
32. Cardiovascular response to muscle relaxation in the dog. Länsimies EA; Klossner JA; Hirvonen L Lab Anim; 1971 Oct; 5(2):173-7. PubMed ID: 4256688 [No Abstract] [Full Text] [Related]
33. [Neuromuscular effects of hexafluorene bromide in association with succinylcholine]. Rodríguez Alvarez E Rev Esp Anestesiol Reanim; 1978 Sep; 25(5):426-44. PubMed ID: 155278 [No Abstract] [Full Text] [Related]
34. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium. Scaf AH; van den Akker J; Westenberg HG Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189 [No Abstract] [Full Text] [Related]
35. Rapid intubation with fazadinium and suxamethonium. Mehta S; Lewin K; Fidler K Can Anaesth Soc J; 1977 Mar; 24(2):270-4. PubMed ID: 14773 [TBL] [Abstract][Full Text] [Related]
36. [Mechanism of the action of myorelaxants]. Beloiartsev FF; Khmelevskiĭ IaM Eksp Khir Anesteziol; 1972; 17(2):85-8. PubMed ID: 4261519 [No Abstract] [Full Text] [Related]
37. Clinical and pharmacological actions of a bolus injection of suxamethonium: two phenomena of distinct duration. d'Hollander AA; Agoston S; De Ville A; Cuvelier F Br J Anaesth; 1983 Feb; 55(2):131-4. PubMed ID: 6131683 [TBL] [Abstract][Full Text] [Related]
38. Neuromuscular effects of pipecuronium bromide. Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856 [TBL] [Abstract][Full Text] [Related]